Adapted response of the antioxidant defense system to oxidative stress induced by deoxynivalenol in Hek-293 cells

Toxicon

Volumn 57, Issue 7-8, 2011, Pages 1023-1032

  Dinu, Diana ^a   Bodea, Gabriela Oana ^a   Ceapa, Corina Diana ^a   Munteanu, Maria Cristina ^a   Roming, Florentina Israel ^b   Serban, Andreea Iren ^a,b   Hermenean, Anca ^c   Costache, Marieta ^a   Zarnescu, Otilia ^a   Dinischiotu, Anca ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

^c VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Bcl 2; Caspase 3; Deoxynivalenol; Lipid peroxidation; Mycotoxins cytotoxicity; Oxidative stress

Indexed keywords

ANTIOXIDANT; CASPASE 3; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; ISOCITRATE DEHYDROGENASE (NADP); LIPID; MALONALDEHYDE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; VOMITOXIN;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROTECTION; CELL STRAIN HEK293; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL DEATH; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; LIPID PEROXIDATION; MYCOTOXINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TIME FACTORS; TRICHOTHECENES;

MAMMALIA;

EID: 79956353020     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.04.006     Document Type: Article

References (53)

1. Aebi H. Catalase in vitro. Methods of Enzymatic Analysis 1984, vol. 2:673-684. F.R.G., Weinheim. H.U. Bergmayer (Ed.).
2. Bensassi F., El Golli-Bennour E., Abid-Essefi S., Bouaziz C., Hajlaoui M.R., Bacha H. Pathway od deoxynivalenol-induced apoptosis in human colon carcinoma cells. Toxicology 2009, 264:104-109.
3. Bernt E., Bergmeyer H.U. Isocitrate dehydrogenase. Methods of Enzymatic Analysis 1974, 624-631. Academic Press, New York. H.U. Bergmeyer (Ed.).
4. Beutler E. Red cell metabolism. A Manual of Biochemical Methods 1971, 71-73. Grune & Stratton, New York. second ed.
5. Blum J., Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch. Biochem. Biophys. 1985, 240:500-508.
6. Bretz M., Beyer M., Cramer B., Knecht A., Humpf H.U. Thermal degradation of the Fusarium mycotoxin deoxynivalenol. J. Agric. Food Chem. 2006, 54:6445-6451.
7. Calvert T.W., Aidoo K.E., Candlish A.G., Fuat A.R. Comparison of in vitro cytotoxicity of Fusarium mycotoxins, deoxynivalenol, T-2 toxin and zearalenone on selected human epithelial cell lines. Mycopathologia 2005, 159:413-419.
8. Cetin Y., Bullerman L.B. Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay. Food Chem. Toxicol. 2005, 43:755-764.
9. Chen Y., McMillan-Ward E., Kong J., Israels D.J., Gibson S.B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15:171-182.
10. Dänicke S., Valenta H., Döll S. On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch. Anim. Nutr. 2004, 58:169-180.
11. Döll S., Dänicke S., Valenta H. Residues of deoxynivalenol (DON) in pig tissue after feeding mash or pellet diets containing low concentrations. Mol. Nutr. Food Res. 2008, 52:727-734.
12. Dragomir-Bodea G.O., Munteanu M.C., Dinu D., Serban A.I., Roming-Israel F., Costache M., Dinischiotu A. Influence of deoxynivalenol on the oxidative status of HepG-2 cells. Rom. Biotechnol. Lett. 2009, 14:4349-4359.
13. European Commission, 2003. Directorate-General Health and Consumer Protection, Reports on tasks for scientific cooperation, report of experts participating in Task 3.2.10: collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states.. http://europa.eu.int/comm/food/fs/scoop/task3210.pdf.
14. Goldberg D.M., Spooner R.J. Glutathione reductase. Methods of Enzymatic Analysis 1983, 258-265. Dearfield Beach. third ed. H.U. Bergmayer (Ed.).
15. Gouze M.E., Gouze J., Laffitte P., Rouimi N., Loiseau N., Oswald I.P., Galtier P. Effect of various doses of deoxynivalenol on liver xenobiotic metabolizing enzymes in mice. Food Chem. Toxicol. 2005, 27:585-590.
16. Greene D.M., Azana-Oliviera J.I., Pestka J.J. Vomitoxin (deoxynivalenol) induced IgA nephropathy in the B6C3F1 mouse: dose-response and male prediction. Toxicology 1994, 92:245-260.
17. Guteb A.C., Morrison E., Murk A.J. Cytotoxicity assays for mycotoxins produced by Fusarium strains: a review. Environ. Toxicol. Pharmacol. 2002, 11:309-320.
18. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
19. Israel-Roming F., Avram M. Deoxynivalenol stability during wheat processing. Rom. Biotechnol. Lett. 2010, 15:47-50.
20. Königs M., Lenczyk M., Schwerdt G., Holzinger H., Gekle N., Humpf H.U. Cytotoxicity, metabolism and cellular uptake of the mycotoxin deoxynivalenol in human proximal tubule cells and lung fibroblasts in primary culture. Toxicology 2007, 240:48-59.
21. Königs M., Schwerdt Gekle N., Humpf H.U. Effects of the mycotoxin deoxynivalenol on human primary hepatocytes. Mol. Nutr. Food Res. 2008, 52:830-839.
22. Kono N.S., Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982, 257:5751-5754.
23. Kouadio J.H., Mobio T.A., Baudrimont I., Moukha S., Dano S.D., Creppy E.E. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 2005, 213:56-65.
24. Kouadio J.H., Dano S.D., Moukha S., Mobio T.A., Creppy E.E. Effects of combinations of Fusarium mycotoxins on the inhibition of macromolecular synthesis, malondialdehyde levels, DNA methylation and fragmentation, and viability in Caco-2 cells. Toxicon 2007, 49:306-317.
25. Krishnaswamy R., Devaraj S.N., Padma V.V. Lutein protects HT-29 cells against deoxynivalenol-induced oxidative stress and apoptosis: prevention of NF-κB nuclear localization and down regulation of NF-κB and cyclo-oxigenase-2 expression. Free Radic. Biol. Med. 2010, 49:50-60.
26. Lohr G.W., Waller H.D. Glucose 6-phosphate Dehydrogenase. Methods of Enzymatic Analysis 1974, 636-646. Verlag Chemie Weinheim, Academic Press, Inc., New York, San Francisco, London. H.U. Bergmayer (Ed.).
27. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall B.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
28. Marks D.B., Marks A.D., Smith C.M. Oxygen metabolism and oxygen toxicity. Basic Medical Biochemistry 1996, 327-340. Wiliams and Wilkins (Ed.).
29. Mates J.M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000, 153:83-104.
30. Minervini F., Fornelli F., Flynn K.M. Toxicity and apoptosis induced by the mycotoxins nivalenol, deoxynivalenol and fumonisin B-1 in a human erythroleukemia cell line. Toxicol. Vitro 2004, 18:21-28.
31. Mosmann J. Rapid colorimetric assay for cellular growth and survived. J. Immunol. Methods 1983, 65:55-63.
32. Paoletti F., Aldinucci D., Mocali A., Caparrini A. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal. Biochem. 1986, 154:538-541.
33. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit beclin 1-Dependent autophagy. Cell 2005, 122:927-939.
34. Pestka J.J., Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B. Crit. Rev. 2005, 8:39-69.
35. Pestka J.J., Zhou H.R., Moon Y., Chung Y.Y. Cellular and molecular mechanism for immune modulation by deoxynivalenol and others trichothecenes: unraveling a paradox. Toxicol. Lett. 2004, 153:61-73.
36. Portoles T.M., Ainaga J.M., Pagani R. The induction of lipid peroxidation by E. coli lipopolysaccharide on rat hepatocytes as an important factor in the etiology of endotoxic liver damage. Biochim. Biophys. Acta 1993, 1158:287-292.
37. Prelusky D.B., Veira D.M., Trenholm H.L., Hartin K.E. Excretion profiles of the mycotoxins deoxynivalenol following oral and intravenous administration to sheep. Fundam. Appl. Toxicol. 1986, 6:356-363.
38. Rizzo A.F., Atroshi F., Ahotupa M., Sankari S., Elovaara E. Protective effect of antioxidants against free radical-mediated lipid peroxidation induced by DON or T-2 toxin. J. Vet. Med. A 1994, 41:81-90.
39. Rocha O., Ansari K., Doohan F.M. Effects of trichothecene mycotoxins on eukaryotic cells: a review. Food Addit. Contam. 2005, 22:369-378.
40. Rook G.A., Steel J., Umar S., Dockrell H.M. A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J. Immunol. Methods 1985, 82:161-167.
41. Rotter B.A., Prelusky D.B., Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 1996, 48:1-34.
42. Sahu S.C., Garthoff L.H., Robl M.G., Chirtel S.J., Ruggles D.I., Flynn T.J., Sobotka T.J. Rat liver clone-9 cells in culture as a model for screening hepatotoxic potential of food-related products: hepatotoxicity of deoxynivalenol. J. Appl. Toxicol. 2008, 28:765-772.
43. Sahu S.C., O'Donnell M.W., Wiesenfeld P.L. Comparative hepatotoxicity od deoxynivalenol in rat, mouse and human liver cells in culture. J. Appl. Toxicol. 2010, 30:566-573.
44. Sun X.M., Zhang X.H., Wang H.Y., Cao W.J., Yan X., Zuo L.F., Wang J.L., Wang F.R. Effects of sterigmatocystin, deoxynivalenol and aflatoxin G1 on apoptosis of human peripheral blood lymphocytes in vitro. Biomed. Environ. Sci. 2002, 15:145-152.
45. Sundstol Eriksen G., Pettersson H. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit. Contam. 2003, 20:579-582.
46. Turner P.C., Rothwell J.A., White K.L.M., Gong Y.Y., Cade J.E., Wild C.P. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom. Environ. Health Perspect 2008, 116:21-25.
47. Valko M., Rhode C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact 2006, 160:1-40.
48. Voehringer D.W. Bcl-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 1999, 9-10:945-950.
49. Walker D.K., Davis J., Houle C., Gardner I.B., Webster R. Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations. Xenobiotica 2009, 39:534-543.
50. Yike I., Allan T., Sorenson W.G., Dearborn D.G. Highly sensitive protein translation assay for trichothecene toxicity in airborne particulates: comparison with cytotoxicity assays. Appl. Environ. Microbiol. 1999, 65:88-94.
51. Yu L., Wan F., Dutta S., Welsh S., Liu Z., Freundt E., Baehrecke E., Lenardo M. Autophagic programmed cell death by selective catalase degradation. Proc. Nat. Acad.Sci. 2006, 103(13):4952-4957.
52. Yuan J., Kroemer G. Alternative cell death mechanisms in development and beyond. Genes Dev. 2010, 24(23):2592-2602.
53. Zhang X., Jiang L., Geng C., Cao J., Zhong L. The role of oxidative stress in deoxynivalenol-induced DNA damage in HepG2 cells. Toxicon 2009, 54:513-518.